Enzyme Linked Immunosorbent Assay (ELISA) Market Size 2021 Global Trend, Share, Segmentation, Business Growth, Top Key Players Analysis, Opportunities and Forecast 2025


Enzyme Linked Immunosorbent Assay, and it is a type of immunoassay that is used to identify proteins, peptides, antibodies, and hormones.

                  Enzyme Linked Immunosorbent Assay (ELISA) Market



Enzyme Linked Immunosorbent Assay, and it is a type of immunoassay that is used to identify proteins, peptides, antibodies, and hormones. The ELISA assay is a diagnostic technique used in biotechnology medicine that uses colour change to identify a target drug and estimate its quantity in a test sample. ELISA is commonly used to diagnose HIV infection, pregnancy testing, and the detection of cytokines, soluble proteins, and other biomarkers. In the immunoassay, several antigen-antibody combinations with an enzyme-labeled antigen or antibody are employed, and enzyme activity is evaluated.


Over the forecast years, the Enzyme Linked Immunosorbent Assay (ELISA) Market is estimated to be driven by the expanding applications of ELISA in oncology and the rising prevalence of infectious disorders and cancer. Researchers and students at biotechnology academic institutes and research laboratories utilise ELISA extensively, which will boost the market.


Market Segmentation:


By Application
  • Cancer
  • HIV AIDS
  • Inflammation Disorders
  • Protein Quantification
  • Others


By Type
  • Sandwich ELISA
  • Indirect ELISA
  • Multiple and Portable ELISA
  • Competitive ELISA


By Geography
  • North America
  • Europe
  • Asia Pacific
  • Rest of the world


Moreover, the market is expected to be fueled by the rising need for cost-effective diagnostic equipment and the rising requirement for regular diagnostic testing among the ageing population over the estimated period. There are a number of constraints and problems that might stymie market expansion. Other immunoassay techniques are expected to operate as a market restriction.


Dengue fever is the most prevalent vector-borne illness, with an estimated 96 million new cases reported each year. Furthermore, developments in ELISA technology are propelling the market forward. For example, in August 2017, University of Illinois, Urbana Campaign researchers created a portable spectrum analyzer based on an ELISA assay that allows a smartphone to do lab-grade medical diagnostic tests that would normally need expensive tools. This test detects and measures a variety of proteins and antibodies in blood, urine, and saliva samples, and is utilised in a number of clinical diagnostic procedures.


The major key players operating the global Enzyme Linked Immunosorbent Assay (ELISA) Market include Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Thermo Fisher Scientific, Inc., Biomerieux S.A., Alpco, BioLegand, Inc., Zeus Scientific, Inc., and Shenzhen YHLO Biotech Co., Ltd.

Comments

Popular posts from this blog

Molecular Sieves Catalyst Market: Global Company Analysis and Forecast 2018 – 2026 | Albemarle Corporation, W. R. Grace and Company, Silkem Ltd., Sinopec Group, and JGC Catalysts & Chemicals Ltd.

Biolubricants Market Size, Share, Growth, Opportunities, Global Analysis and Opportunity Assessment 2019 – 2027

Shared Services Market by Function, By Number of Services and By Region – Global Opportunities & Forecast 2019 - 2027